rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
47
|
pubmed:dateCreated |
2000-1-4
|
pubmed:abstractText |
The TRAIL death receptor KILLER/DR5 is induced by DNA damaging agents in wild-type p53-expressing cells. Here we show that, unlike the p53-target CDK-inhibitor p21WAF1/CIP1, the TRAIL death receptor KILLER/DR5 is only induced in cells undergoing p53-dependent apoptosis and not cell cycle arrest. Thus GM glioblastoma cells carrying an inducible MMTV-driven p53 gene undergo cell cycle arrest and upregulate p21 but not KILLER/DR5 expression upon dexamethasone exposure. WI38 normal lung fibroblasts undergoing cell cycle arrest in response to ionizing irradiation also induce p21 but not KILLER/DR5 gene expression. KILLER/DR5 upregulation is also deficient in irradiated lymphoblastoid cells derived from patients with Ataxia Teleangiectasia suggesting a role for the ATM-p53 pathway in regulating KILLER/DR5 expression after DNA damage. Inhibition of transcription by Actinomycin D blocks both KILLER/DR5 and p21 induction in cells undergoing p53-dependent apoptosis. Our results suggest that the p53-dependent transcriptional induction of KILLER/DR5 death receptor is restricted to cells undergoing apoptosis and not cells undergoing exclusively p53-dependent G1 arrest.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cell Cycle Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, TNF-Related...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TNFRSF10B protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/ataxia telangiectasia mutated...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0950-9232
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
11
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6411-8
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:10597242-Apoptosis,
pubmed-meshheading:10597242-Cell Cycle Proteins,
pubmed-meshheading:10597242-Cell Division,
pubmed-meshheading:10597242-Cell Line,
pubmed-meshheading:10597242-DNA-Binding Proteins,
pubmed-meshheading:10597242-Humans,
pubmed-meshheading:10597242-Protein-Serine-Threonine Kinases,
pubmed-meshheading:10597242-Receptors, TNF-Related Apoptosis-Inducing Ligand,
pubmed-meshheading:10597242-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:10597242-Transcription, Genetic,
pubmed-meshheading:10597242-Tumor Cells, Cultured,
pubmed-meshheading:10597242-Tumor Suppressor Protein p53,
pubmed-meshheading:10597242-Tumor Suppressor Proteins
|
pubmed:year |
1999
|
pubmed:articleTitle |
Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest.
|
pubmed:affiliation |
Department of Medicine, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine Philadelphia 19104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|